<p>In the first part of the podcast, Dr. Jason Crowell discusses the business of Alzheimer disease and how to approach teaching patients about aducanumab with Dr. Jason Karlawish. In the second segment, Dr. Jennifer Bickel talks with Dr. Eric Kaiser about the contribution of melanopsin and cone signals to light-induced reflexive eye closure in migraine.</p>

In the first part of the podcast, Dr. Jason Crowell discusses the business of Alzheimer disease and how to approach teaching patients about aducanumab with Dr. Jason Karlawish. In the second segment, Dr. Jennifer Bickel talks with Dr. Eric Kaiser about the contribution of melanopsin and cone signals to light-induced reflexive eye closure in migraine.

Aducanumab and the Business of Alzheimer Disease; Implicit Light Sensitivity in Migraine

The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.

Share Aducanumab and the Business of Alzheimer Disease; Implicit Light Sensitivity in Migraine

Sign up to save your podcasts

Aducanumab and the Business of Alzheimer Disease; Implicit Light Sensitivity in Migraine

Aducanumab and the Business of Alzheimer Disease; Implicit Light Sensitivity in Migraine

More shows like Neurology® Podcast

JAMA Editors' Summary

NEJM This Week

Practical Neurology Podcast

JAMA Clinical Reviews

The Curbsiders Internal Medicine Podcast

JAMA Neurology Author Interviews

Core IM | Internal Medicine Podcast

Neurology Today in 5

Annals On Call Podcast

The Clinical Problem Solvers

Neurology Minute

Harrison's PodClass: Internal Medicine Cases and Board Prep

Neurology Exam Prep Podcast

The Curious Clinicians

Continuum Audio